Search Results for " Simvastatin "
Simvastatin EP Impurity C
| N° de SZ CAT: | SZ-S008004 |
| Número CAS | 210980-68-0 |
| Mol.F. | C25H36O4 |
| Peso Molecular | 400.6 |
| Status de Fatura | In Stock |
| Shipping Condition | Ambient Temperature |
Nome Químico: (1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate (as per EP & USP)
Sinônimo: Simvastatin USP Related Compound C ; 2,3-Anhydro Simvastatin ; Dehydro Simvastatin ; Simvastatin Dehydration Product ; Anhydro simvastatin (USP)
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: [H][C@@]1([C@H]([C@H](C=C2)C)CC[C@H]3OC(C=CC3)=O)C2=C[C@@H](C[C@@H]1OC(C(C)(CC)C)=O)C
Simvastatin EP Impurity C is chemically (1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate (as per EP & USP). It is also known as Simvastatin USP Related Compound C ; 2,3-Anhydro Simvastatin ; Dehydro Simvastatin ; Simvastatin Dehydration Product ; Anhydro simvastatin (USP). Simvastatin EP Impurity C is supplied with detailed characterization data compliant with regulatory guideline. Simvastatin EP Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Simvastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
products.relatedproducts
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.